rs876657805
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001201397.2(EDNRB):c.7A>T(p.Lys3*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001201397.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDNRB | NM_001201397.2 | c.7A>T | p.Lys3* | stop_gained | Exon 1 of 8 | NP_001188326.1 | ||
EDNRB | NM_000115.5 | c.-51-985A>T | intron_variant | Intron 1 of 7 | NP_000106.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDNRB | ENST00000377211.8 | c.7A>T | p.Lys3* | stop_gained | Exon 1 of 8 | 1 | ENSP00000366416.4 | |||
EDNRB | ENST00000646948.1 | c.-51-985A>T | intron_variant | Intron 1 of 7 | ENSP00000493895.1 | |||||
OBI1-AS1 | ENST00000607862.5 | n.-80T>A | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Lys3X variant in EDNRB (NM_001201387.1) has not been previously reported i n individuals with hearing loss, type 4 Waardenburg syndrome, or Hirschsprung di sease, and was absent from large population studies. This nonsense variant affec ts the coding region of only one of four transcript isoforms of the EDNRB gene a nd exon 1 of this isoform lies in either intergenic or intronic regions of the o ther EDNRB isoforms. In addition, pathogenic variants in exon 1 of this transcri pt have not been reported in affected individuals and this exon is enriched for loss of function variants compared with other exons of this gene in the control population (ExAC, http://exac.broadinstitute.org). This suggests that this exon and/or transcript may not be critical for a functional protein; however, additio nal studies are needed to confirm this. In summary, the clinical significance of this variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at